CLINICAL_TRIALS trial_result · 2026-08-17

Clinical Trial Results: Mesothelioma Stratified Therapy (MiST) : A Multi-drug Phase II Trial in Malignant Mesothelioma [Phase 2]

Phase II multi-drug trial (MiST) in malignant mesothelioma has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: University of Leicester | Conditions: Mesothelioma, Malignant | Phase 2 | Status: COMPLETED | Results posted: 2026-08-17